Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Repeated dose toxicity: oral

Currently viewing:

Administrative data

Endpoint:
sub-chronic toxicity: oral
Type of information:
migrated information: read-across from supporting substance (structural analogue or surrogate)
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Guideline study performed under GLP. Piperazine is one constituent (ca. 15%) of the test substance.

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1999
Report date:
1999

Materials and methods

Test guideline
Guideline:
other: FDA 1986, Toxicological principles for Safety Assessment of Direct Food Additives and Color Additives Used in Food
GLP compliance:
yes
Limit test:
no

Test material

Constituent 1
Reference substance name:
Piperazine dihydrochloride
EC Number:
205-551-2
EC Name:
Piperazine dihydrochloride
Cas Number:
142-64-3
IUPAC Name:
piperazine dihydrochloride
Details on test material:
- Name of test material (as cited in study report): piperazine dihydrochloride
- Analytical purity: 52.25% as piperazine base

Test animals

Species:
rat
Strain:
Sprague-Dawley
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Charles River Laboratories
- Age at study initiation: 6 weeks
- Weight at study initiation: M: 205 g F 156 g
- Acclimation period: 2 weeks


ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20-24
- Humidity (%): 36 - 74%
- Photoperiod (hrs dark / hrs light): 12 h cycle


Administration / exposure

Route of administration:
oral: feed
Vehicle:
unchanged (no vehicle)
Details on oral exposure:
DIET PREPARATION
- Rate of preparation of diet: Weekly
- Mixing appropriate amounts with: Certified Rodent Diet No. 5002
Analytical verification of doses or concentrations:
yes
Duration of treatment / exposure:
90 days
Frequency of treatment:
7 days/week
Doses / concentrationsopen allclose all
Remarks:
Doses / Concentrations:
400 mg/kg bw/day
Basis:
actual ingested
Remarks:
Doses / Concentrations:
1200 mg/kg bw/day
Basis:
actual ingested
Remarks:
Doses / Concentrations:
2394 mg/kg bw/day
Basis:
actual ingested
No. of animals per sex per dose:
20
Control animals:
yes, concurrent no treatment

Examinations

Observations and examinations performed and frequency:
DETAILED CLINICAL OBSERVATIONS: Yes
- Time schedule: Weekly

BODY WEIGHT: Yes
- Time schedule for examinations: Twice pre-test, weekly during treatment and terminally after fasting.

FOOD CONSUMPTION AND COMPOUND INTAKE:
- Food consumption for each animal determined and mean daily diet consumption calculated as g food/kg body weight/day: Yes
- Compound intake calculated as time-weighted averages from the consumption and body weight gain data: Yes

OPHTHALMOSCOPIC EXAMINATION: Yes
- Time schedule for examinations: pre test: day -5 and at termination day 92

HAEMATOLOGY: Yes
- Time schedule for collection of blood: Day 0, test day 46, and at termination day 92 and 94
- How many animals: 10/sex/group

CLINICAL CHEMISTRY: Yes
- Time schedule for collection of blood: Day 0, test day 46, and at termination day 93 and 94
- How many animals: 10/sex/group

URINALYSIS: Yes
- Time schedule for collection of urine: Day -6, test day 43, and at termination day 87

NEUROBEHAVIOURAL EXAMINATION: No
Sacrifice and pathology:
GROSS PATHOLOGY: Yes
HISTOPATHOLOGY: Yes

Results and discussion

Results of examinations

Urinalysis findings:
no effects observed
Behaviour (functional findings):
not examined
Histopathological findings: non-neoplastic:
no effects observed
Details on results:
BODY WEIGHT AND WEIGHT GAIN
Dose-related decreases in body weight gain, with a difference to control of 10% occurred in the high dose group.

Effect levels

open allclose all
Dose descriptor:
NOAEL
Effect level:
1 200 mg/kg bw/day (actual dose received)
Sex:
male/female
Basis for effect level:
other: Decrease in body weight gain
Dose descriptor:
NOAEL
Effect level:
627 mg/kg bw/day (actual dose received)
Sex:
male/female
Basis for effect level:
other: Recalculated to Piperazine base

Target system / organ toxicity

Critical effects observed:
not specified

Applicant's summary and conclusion

Conclusions:
NOAEL for sub-chronic repeated dose toxicity to the rat is 627 mg/kg bw/day.
Executive summary:

In a 90-day study rats were dosed with Piperazine-dihydrochloride administred in the diet. The doses were 400, 1200 and 2394 mg/kg bw/day, administered to 20 animals/sex/dose. The only effects noted was a dose related decrease in body-weight gain. NOAEL for repeated dose toxicity to the rat was 627 mg/kg bw/day, recalculated to piperazine base.